Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study.
about
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study.Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study.
P2860
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resource use and costs of exen ...... ce: the European CHOICE study.
@en
Resource use and costs of exen ...... ce: the European CHOICE study.
@nl
type
label
Resource use and costs of exen ...... ce: the European CHOICE study.
@en
Resource use and costs of exen ...... ce: the European CHOICE study.
@nl
prefLabel
Resource use and costs of exen ...... ce: the European CHOICE study.
@en
Resource use and costs of exen ...... ce: the European CHOICE study.
@nl
P2093
P2860
P50
P356
P1476
Resource use and costs of exen ...... ce: the European CHOICE study.
@en
P2093
Bruno Guerci
Claes-Göran Ostenson
Hélène Sapin
Jacek Kiljański
Matthew Reaney
Michael Theodorakis
Stephan Matthaei
Thure Krarup
Urpo Kiiskinen
P2860
P304
P356
10.2147/CEOR.S44060
P407
P577
2013-07-11T00:00:00Z